AEROSOLIZED DRUG DELIVERY - FRACTIONAL DEPOSITION OF INHALED PARTICLES

被引:8
作者
BENNETT, WD
机构
[1] Center for Environmental Medicine and Lung Biology, University of North Carolina at Chapel Hill, Chapel Hill
来源
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG | 1991年 / 4卷 / 03期
关键词
AEROSOLS; DEPOSITION; AEROSOL DRUG DELIVERY;
D O I
10.1089/jam.1991.4.223
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Delivery of drugs by aerosol is increasingly used as a means of providing therapy to both the lungs and to the rest of the body through absorption into the pulmonary circulation. The techniques, definitions, and terminology for aerosol delivery are not standardized or necessarily understood by the increasing number of clinicians and clinical investigators involved in these studies. This paper attempts to establish some definitions and guidelines for defining and characterizing deposition of aerosols in the respiratory tract. Some of the parameters that affect deposition are discussed (e.g., particle size, breathing pattern, airway caliber). It is suggested that these parameters be controlled or measured when characterizing new aerosol delivery systems for clinical investigations. These recommendations were discussed and agreed upon during an expert meeting on definitions and standards related to aerosols in medicine at the 8th Congress of ISAM. © 1991, Mary Ann Liebert, Inc. All rights reserved.
引用
收藏
页码:223 / 227
页数:5
相关论文
共 12 条
[1]  
BENNETT W.D., MESSINA M., SMALDONE G.C., Effect of exercise on deposition and subsequent retention of inhaled particles, J Appl Physiol, 59, pp. 1046-1054, (1985)
[2]  
BENNETT W.D., SMALDONE G.C., Human variation in the peripheral air-space deposition of inhaled particles, J Appl Physiol, 62, pp. 1603-1610, (1987)
[3]  
DAVIES C.N., LEVER M., ROTHENBERG S., Experimental studies of the deposition of particles in the human lungs, In: Inhaled Particles, 4, pp. 151-162, (1977)
[4]  
DOLOVICH M.B., SANCHIS J., ROSSMAN C., NEWHOUSE M.T., Aerosol penetrance: a sensitive index of peripheral airways obstruction, J Appl Physiol, 40, pp. 468-471, (1976)
[5]  
HEYDER J., ARMBRUSTER L., GEBHART J., GREIN E., STAHLHOFEN W., Total deposition of aerosol particles in the human respiratory tract for nose and mouth breathing, J Aerosol Sci, pp. 311-328, (1975)
[6]  
HEYDER J., GEBHART J., SCHEUCH G., Influence of human lung morphology on particle deposstion, J Aerosol Med, 1, 2, pp. 81-88, (1988)
[7]  
ILOWITE J.S., GORVOY J.D., SMALDONE G.C., Quantitative deposition of aerosolized gentamicin in cystic fibrosis, Am Rev Respir Dis, 136, pp. 1445-1449, (1987)
[8]  
LAUBE B.L., SWIFT D.L., WAGNER H.N., NORMAN P.S., ADAMS G.K., The effect of bronchial obstruction on central airway deposstion of a saline aerosol in patients with asthma, Am Rev Respir Dis, 133, pp. 740-743, (1986)
[9]  
LEWIS R.A., FLEMING J.S., Fractional deposstion from a jet nebulizer: how it differs from a metered dose inhaler, Br J Dis Chest, 79, pp. 361-367, (1985)
[10]  
LOVE R.G., MUIR D.C.F., Aerosol deposition and airway obstruction, Am Rev Respir Dis, 114, pp. 891-897, (1976)